Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry ...

- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne - - Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 ...

In response to this global need for more universal and broadly deliverable, frontline treatments, Algernon Pharmaceuticals ...

PPX Mining Corp. (TSXV:PPX)(BVL:PPX) (the "Company" or "PPX", including its Peruvian subsidiaries) is pleased to announce that a 2,222 DMT lot of sulfide ore from the Callanquitas Mine was sent to a ...

STAR-1 topline results expected in March 2025 - - Over 30 million acne patients seek treatment in the U.S. each year - - Phase 2b for DMT310 achieved statistically significant r ...

Copper (“Cu”) and gold (“Au”) accounted for 78% and 22% of the 11,936 (Q3-2023 – 8,325) dry metric tonnes (“DMT”) sold during Q3-2024.

“I'm waiting to do an actual musical film. I want to sing,” Evans tells PEOPLE. “[And] dance. That is what I want.” “Let’s manifest that, man,” says his costar Johnson, 52.

GH002 is our mebufotenin (5-MeO-DMT) product candidate formulated for administration via a proprietary intravenous ... Such statements are subject to risks and uncertainties, and actual results may ...

Recent Clinical Highlights VLS-01: N,N-dimethyltryptamine (DMT) for Treatment-Resistant Depression ... risks and uncertainties that could cause actual results to differ materially from those ...